Sistemde güncelleme ve geliştirme çalışmaları devam etmektedir

The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer …

KIRIKKALE UNIVERSITY Career
Staff Login Login

Publication

The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer …

01 Ocak 2024 Makale Google Scholar

Atıf kopyala

P. S. YALÇIN (2024). The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer …. *International journal of clinical oncology 29 (3), 258-265, 2024*.

Yayın bilgileri

Dergi International journal of clinical oncology 29 (3), 258-265, 2024
Veri tabanı Google Scholar
Kaynak GoogleScholar

Atıf verisi 16 Kasım 2026 tarihinde güncellendi.

HÇ Yıldırım, Y Kutlu, E Mutlu, MB Aykan, M Korkmaz, S Yalçın, T Şakalar, ... | International journal of clinical oncology 29 (3), 258-265, 2024

Citations by source

Kaynak Atıf
Google Scholar 11
Etkin 0

Yayın metrikleri (GS / WoS / Scopus)

11 Google Scholar Atıf
AI Assistant
Online